TENS for Phantom Limb Pain Prevention Following Major Amputation

Transcutaneous Electrical Nerve Stimulation (TENS) for Phantom Limb Pain Prevention Following Arteriopathic Major Amputation: Clinical Trial

A growing body of literature indicates that up to 80% of amputees may have phantom limb pain (PLP). The first cause for limb loss is vascular disease. Usually, amputees who suffer from PLP are suboptimal treated. Therefore, many amputees are disabled by their chronic pain. The etiology and pathophysiology of PLP are poorly understood. Some studies suggest a somatosensory cortex reorganization. Transcutaneous Electrical Nerve Stimulation (TENS) is a analgesic technique. TENS apply a low voltage electrical current through the skin using surface electrodes in order to stimulate afferent nerve fibbers. Because of the lack of evidence to support any treatment for PLP, interest has turned to preventing it instead.

The aim of this study is to assess if the early use of TENS in the immediately postoperative of major limb amputation due to peripheral vascular disease, should decrease the PLP incidence. TENS should interfere in the mechanism of PLP production to level of the pain fibers conduction.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Introduction:

Postamputation pain is highly prevalent after vascular limb amputation. The physiopathological basis should be divided in supraspinal, spinal and peripheral mechanisms. Supraspinal mechanism involve somatosensory cortical reorganization; spinal reorganization in the dorsal horn, occurs after deafferentation from peripheral nerve injury and peripherical nerve injury begins with the nerve section in surgery. All this factors seems to end into a somatosensory cortex reorganization. In this sense, it seems that our ability to prevent PLP depend on the capability to modulate the plasticity of the Central Nervous System (CNS).

Transcutaneous electrical nerve stimulation it´s a safe, easy and inexpensive analgesic technique acting on the conduction pathways of pain. An adequated program is mandatory: balanced symmetrical biphasic pulse, pulse length greater than 250microsg, modulated high frequency and electrodes placed over the dermatomes corresponding to lumbar-sacral spine; will be used in the intervention patients

Hypothesis:

In patients with TENS use during the immediately postoperative of major limb amputation due to peripheral vascular disease, phantom limb pain will appear with less frequency than in control patients.

Study population:

Patients undergoing major limb amputation for peripheral vascular disease.

Study design:

A randomized, prospective, blinded (patient, physician, statistician),clinical trial placebo versus intervention group study has been design.

In the intervention arm, TENS should be applied during the 24 hours immediately after limb amputation. The placebo arm, also will carry TENS but without an active program.

All patients should receive the standard analgesic treatment for limb amputation during their hospitalization time.

Evaluation and objectives:

Before surgery all patients made two test for pain evaluation: The Analogical Visual Scale and the DN4 questionnaire for neuropathic pain.

At 3 days, 1 month and 3 months after surgery, all patients will be evaluated about their pain using the recommended test for neuropathic pain:The Analogical Visual Scale and the DN4 (neuropathic pain 4) questionnaire for neuropathic pain . Also, at month 1 and 3th, two more test should be done in order to evaluate quality of life: The SF-12 (short form-12) health survey questionnaire about health and the Medical Outcomes Study (MOS) for sleep test.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Castellon de la Plana, Spain, 12004
        • Recruiting
        • Hospital General Universitario de Castellon
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age over 18 years of both genders
  • Critical limb ischemia (arteriopathic or diabetic aetiology)
  • "MINI MENTAL TEST" (minimum 24 points)

Exclusion Criteria:

  • Pace marker
  • Don´t speak Spanish
  • Not agreement with the study
  • Dermatological lesion affecting the electrode place

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: TENS INTERVENTION
In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours. The intensity of the impulse will be determined in a test carried out 3 days before surgery. The other parameters will be continuous, biphasic, compensated and symmetric impulse, frequency of 80 Hz, time impulse between 250 and 290 microseconds, modulation time 5´´
24 hours of TENS treatment in the immediately postoperative of limb amputation
PLACEBO_COMPARATOR: TENS NO INTERVENTION
In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours, but in this case TENS just will be on. No intensity impulse should be programmed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PREOPERATIVE PAIN EVALUATION
Time Frame: 3 days before intervention
Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10 DN4 Test ( for neurophatic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neurophatic pain.
3 days before intervention
PREOPERATIVE NEUROPAThIC PAIN EVALUATION
Time Frame: 3 days before intervention
DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.
3 days before intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
INMEDIATELY POSTOPERATIVE PAIN EVALUATION
Time Frame: 3 days after intervention
Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10
3 days after intervention
INMEDIATELY POSTOPERATIVE PAIN EVALUATION
Time Frame: 3 days after intervention
DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.
3 days after intervention
1 MONTH POSTOPERATIVE PAIN EVALUATION
Time Frame: 1 MONTH
Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10
1 MONTH
1 MONTH POSTOPERATIVE PAIN EVALUATION
Time Frame: 1 MONTH
DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.
1 MONTH
1 MONTH POSTOPERATIVE HEALTH EVALUATION
Time Frame: 1 MONTH
Test SF-12 about health situation. This is the recommended test of the Spanish Pain society for subjective evaluation of health situations. It consist in 12 questions about its own perceptions, employment status, daily activities, frame of mind
1 MONTH
1 MONTH POSTOPERATIVE SLEEP EVALUATION
Time Frame: 1 MONTH
Test MOS (Sleep Scale from the Medical Outcomes Study) Some questions for sleep evaluation
1 MONTH
3 MONTH POSTOPERATIVE PAIN EVALUATION
Time Frame: 3 MONTH
Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10
3 MONTH
3 MONTH POSTOPERATIVE PAIN EVALUATION
Time Frame: 3 MONTH
DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.
3 MONTH
3 MONTH POSTOPERATIVE HEALTH EVALUATION
Time Frame: 3 MONTH
Test SF-12 about health situation. This is the recommended test of the Spanish Pain society for subjective evaluation of health situations. It consist in 12 questions about its own perceptions, employment status, daily activities, frame of mind
3 MONTH
3 MONTH POSTOPERATIVE SLEEP EVALUATION
Time Frame: 3 MONTH
Test MOS (Sleep Scale from the Medical Outcomes Study) Some questions for sleep evaluation
3 MONTH

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Barbara Bodega, Mrs, Hospital General Universitario de Castellon. Avenida Benicassim sn 12004. Castellon. Spain

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (ANTICIPATED)

November 1, 2016

Study Completion (ANTICIPATED)

March 1, 2017

Study Registration Dates

First Submitted

July 9, 2015

First Submitted That Met QC Criteria

July 9, 2015

First Posted (ESTIMATE)

July 14, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

July 15, 2015

Last Update Submitted That Met QC Criteria

July 14, 2015

Last Verified

June 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Vascular Diseases

Clinical Trials on TENS INTERVENTION

Subscribe